The Standard | by Graham Kajilwa
The Pharmacy and Poisons Board (PPB) has given Emergency Use Approval for the Russian-developed Covid-19 vaccine, Sputnik V, in Kenya through a private pharmacy.
The Sputnik V vaccine has an efficacy level of about 92 per cent and is the first such private consignment in Kenya. But its use is subject to certain conditions among them proof of linking Sputnik V vaccine to the ongoing national vaccination roll-out plan.
According to a source at the PPB, several other vaccine manufacturers have expressed interest, but are yet to…
